Detalhe da pesquisa
1.
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer.
Breast Cancer Res Treat
; 198(2): 217-229, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36735117
2.
Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR).
Oncologist
; 26(7): 560-e1103, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33829609
3.
An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma.
Oncologist
; 24(2): 202-210, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190302
4.
Endoglin: a novel target for therapeutic intervention in acute leukemias revealed in xenograft mouse models.
Blood
; 129(18): 2526-2536, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28351936
5.
Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody.
Eur J Nucl Med Mol Imaging
; 45(1): 123-131, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28821931
6.
86/90Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model.
Mol Pharm
; 15(7): 2606-2613, 2018 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29787283
7.
Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry.
Proc Natl Acad Sci U S A
; 112(41): 12806-11, 2015 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-26417085
8.
ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment.
Mol Pharm
; 14(5): 1646-1655, 2017 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28292180
9.
High Yield Production and Radiochemical Isolation of Isotopically Pure Arsenic-72 and Novel Radioarsenic Labeling Strategies for the Development of Theranostic Radiopharmaceuticals.
Bioconjug Chem
; 27(1): 179-88, 2016 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26646989
10.
Novel Preparation Methods of (52)Mn for ImmunoPET Imaging.
Bioconjug Chem
; 26(10): 2118-24, 2015 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26317429
11.
Effects of the combination of TRC105 and bevacizumab on endothelial cell biology.
Invest New Drugs
; 32(5): 851-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24994097
12.
In vivo tumor vasculature targeted PET/NIRF imaging with TRC105(Fab)-conjugated, dual-labeled mesoporous silica nanoparticles.
Mol Pharm
; 11(11): 4007-14, 2014 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24937108
13.
Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.
Angiogenesis
; 16(3): 663-74, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23471463
14.
A phase 1 study of TRC102, an inhibitor of base excision repair, and pemetrexed in patients with advanced solid tumors.
Invest New Drugs
; 31(3): 714-23, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23054206
15.
PET imaging of CD105/endoglin expression with a 6¹/64Cu-labeled Fab antibody fragment.
Eur J Nucl Med Mol Imaging
; 40(5): 759-67, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23344138
16.
Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105.
Mol Pharm
; 10(7): 2749-56, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23738915
17.
Positron emission tomography imaging of tumor angiogenesis with a (61/64)Cu-labeled F(ab')(2) antibody fragment.
Mol Pharm
; 10(2): 709-16, 2013 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23316869
18.
Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial.
Commun Med (Lond)
; 3(1): 120, 2023 Sep 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37684373
19.
Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis.
Clin Cancer Res
; 29(18): 3744-3758, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432984
20.
Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody.
Mol Pharm
; 9(3): 645-53, 2012 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-22292418